Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
<p><strong>Background: </strong>There is no generally accepted methodology for in vivo assessment of antiviral activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a treatment of COVID-19, but whether it has clinically significant antiviral activity...
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Diğer Yazarlar: | |
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
eLife Sciences Publications
2023
|